| Shirley Mucha, APRN, BC | |
|
3811 O Hara St, Erc 712, Pittburgh, PA 15213 | |
| (412) 246-5323 | |
| Not Available |
| Full Name | Shirley Mucha |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 3811 O Hara St, Pittburgh, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992977664 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | RN 174829-L (Pennsylvania) | Primary |
| Entity Name | Upmc Presbyterian Shadyside |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821007881 PECOS PAC ID: 3870401847 Enrollment ID: O20031124000048 |
News Archive
Researchers from the BC Centre for Excellence in HIV/AIDS and the University of British Columbia today released a comprehensive study revealing that the 2008 IAS-USA therapy guidelines for commencing HIV treatment would create significant benefits for individuals infected with HIV and society as a whole.
Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.
The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer.
Although Uganda had many achievements to celebrate on the anniversary of its independence on Wednesday, the country must "focus on independence on the individual level," especially among women affected by HIV/AIDS in the country, Milly Nattimba of the Makerere University School of Public Health writes in a New Vision opinion piece.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shirley Mucha, APRN, BC 3811 O Hara St, Erc 712, Pittburgh, PA 15213 Ph: (412) 246-5323 | Shirley Mucha, APRN, BC 3811 O Hara St, Erc 712, Pittburgh, PA 15213 Ph: (412) 246-5323 |
News Archive
Researchers from the BC Centre for Excellence in HIV/AIDS and the University of British Columbia today released a comprehensive study revealing that the 2008 IAS-USA therapy guidelines for commencing HIV treatment would create significant benefits for individuals infected with HIV and society as a whole.
Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.
The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer.
Although Uganda had many achievements to celebrate on the anniversary of its independence on Wednesday, the country must "focus on independence on the individual level," especially among women affected by HIV/AIDS in the country, Milly Nattimba of the Makerere University School of Public Health writes in a New Vision opinion piece.
› Verified 5 days ago